Hipercoagulabilidade secundária ao hiperadrenocorticismo em cães: Revisão

Hyperadrenocorticism or Cushing's Syndrome is an endocrinopathy characterized by a high concentration of cortisol in the circulation. This hormone is responsible for numerous changes in the body, including increased clotting that contributes to the formation of thrombi. This complication is con...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PUBVET 2021-10, Vol.15 (10), p.1-6
Hauptverfasser: Almeida, Gabriela Barbosa de, Santos de Miranda, Mariana, Segalla Caragelasco, Douglas, Andrade de Barros, Michele
Format: Artikel
Sprache:eng ; por
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hyperadrenocorticism or Cushing's Syndrome is an endocrinopathy characterized by a high concentration of cortisol in the circulation. This hormone is responsible for numerous changes in the body, including increased clotting that contributes to the formation of thrombi. This complication is considered highly fatal, in this sense, the objective of the present study was to understand, through literature and academic review of scientific papers, the pathophysiology of hypercoagulability secondary to hyperadrenocorticism, in addition to identifying diagnostic methods for such anomalies and their possible treatments. Numerous possibilities have been found to explain the increase in coagulation, however, all the theories cited by the authors are still poorly understood. The diagnosis of Cushing's Syndrome can be made by several methods, the most used being the low dose dexamethasone suppression test. Hypercoagulability, on the other hand, may be identified through thromboelastrography or rotational thromboelastometry, these tests may fully evaluate hemostasis. In addition to these tests, other diagnostic methods can also assist in the assessment of the animal's hemostatic situation, such as platelet count, measurement of coagulation factors, fibrinogen concentration, among others. The treatment of hyperadrenocorticism basically consists of the administration of trilostane or mitotane. Nevertheless, the control of this hormone does not guarantee a significant improvement in the hypercoagulable state present in the patient, since cortisol has a prolonged effect on the body and depending on the dosage established for a period of time without action of the medication. Hence, this complication must be treated when the tests show signs of hypercoagulability or when the animal has a concomitant condition that predisposes to the formation of thrombi, and then establishes anticoagulant therapy. O Hiperadrenocorticismo ou Síndrome de Cushing é uma endocrinopatia caracterizada pela elevada concentração de cortisol na circulação. Esse hormônio é responsável por inúmeras alterações no organismo, dentre elas o aumento da coagulação que contribui para a formação de trombos. Essa complicação é considerada fatal, nesse sentido, o objetivo do presente estudo foi, através de revisões literárias e acadêmicas de artigos científicos, compreender a fisiopatologia da hipercoagulabilidade secundária ao hiperadrenocorticismo, além de identificar métodos diagnósticos para tais anomalias e
ISSN:1982-1263
1982-1263
DOI:10.31533/pubvet.v15n10a929.1-16